Clinical trial
Effect of Vitamin D Replacement on Tumor Response and Survival Parameters for Vitamin D Insufficient Patients With Cancer
NCT01787409 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Vitamin D Replacement on Tumor Response and Survival Parameters for Vitamin D Insufficient Patients With Cancer
- Lead sponsor
- Mayo Clinic
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 6, 2013
- Completion date
- June 30, 2028
- Enrollment
- 565 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
aggressive non-hodgkin lymphoma, anaplastic large cell lymphoma, angioimmunoblastic t-cell lymphoma, chronic lymphocytic leukemia, diffuse large b-cell lymphoma, enteropathy-associated t-cell lymphoma, hepatosplenic t-cell lymphoma, mature t-cell and nk-cell non-hodgkin lymphoma, mediastinal (thymic) large b-cell lymphoma, nasal type extranodal nk/t-cell lymphoma, peripheral t-cell lymphoma, not otherwise specified, primary cutaneous anaplastic large cell lymphoma, refractory anaplastic large cell lymphoma, small lymphocytic lymphoma, subcutaneous panniculitis-like t-cell lymphoma